Optometrists in Byram, MS Accepting Medicare

4 Optometrists found. Showing 1 - 4

Dr. Sidney Maurice Wilson, O.D. Optometrist - Corneal and Contact Management Medicare: Medicare Enrolled Practice Location: 6745 S Siwell Rd, Suite 106, Byram, MS 39272 Phone: 601-373-0354    Fax: 601-373-0321

Mississippi Eyecare Associates Of Byram, Pllc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7118b S Siwell Rd, Byram, MS 39272 Phone: 601-398-3000    Fax: 601-398-3002

Ms. Deandre Monique Carr, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 131 Handley Boulevard, Byram, MS 39272 Phone: 601-346-7549    Fax: 601-346-7927

Eyeology Eyecare, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 131 Handley Blvd, Byram, MS 39272 Phone: 601-346-7549

News Archive

Laser Spine Institute opens medical consultation facilities in Beverly Hills and Fort Lauderdale

After helping thousands of patients get their lives back through minimally invasive endoscopic spine surgery at facilities in Tampa, Scottsdale, and soon in Philadelphia, the Laser Spine Institute (LSI) announces the opening of their newest medical consultation facilities - in Beverly Hills, Ca., and Fort Lauderdale, Fla., in October - which aim to meet the growing demand for LSI's spinal procedures and provide greater convenience for local patients.

VitaPath Genetics launches VitaTrack Folate Tracker

VitaPath Genetics, the Spina Bifida Association and the National Council on Folic Acid today announced the launch of the free iPhone application—the VitaTrack Folate Tracker— which allows women to track their daily intake of folate and folic acid. Maintaining an adequate level of folic acid prior to and during pregnancy can reduce the risk of serious birth defects like Spina Bifida by up to 70%. Studies show that folic acid may also help prevent congenital heart disease, pre-term labor, and cleft lip and palate.

Data from Janssen's SIMPONI Phase 3 study on ulcerative colitis

New study findings presented today show that subcutaneous induction regimens of the anti-tumor necrosis factor (TNF)-alpha therapy SIMPONI (golimumab) induced clinical response in a majority of patients with moderately to severely active ulcerative colitis (UC) who had previously failed or were intolerant to conventional agents.

Socioeconomic status of patient linked to choice of treatment

Though it would seem logical, cancer patients don't always choose therapies with the best chance for survival-cost and side effects are also major considerations. Little has been known about the extent to which cost and side effects influence a patient's treatment decision. Now, new findings by Fox Chase Cancer Center researchers reveals that a patient's socioeconomic status, more than any other characteristic-such as age or disease site-is predictive of whether he or she will favor high efficacy, low cost or low toxicity when choosing a treatment.

Read more Medical News

› Verified 5 days ago